BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11168337)

  • 1. HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population.
    Kelly MA; Chan JC; Heward J; Mijovic CH; Zimmet PZ; Yeung VT; Cockram C; Barnett AH
    Diabet Med; 2001 Jan; 18(1):22-8. PubMed ID: 11168337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
    Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
    Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?
    Tiberti C; Buzzetti R; Anastasi E; Dotta F; Vasta M; Petrone A; Cervoni M; Torresi P; Vecci E; Multari G; Di Mario U
    Diabetes Metab Res Rev; 2000; 16(1):8-14. PubMed ID: 10707033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
    Stayoussef M; Benmansour J; Al-Jenaidi FA; Said HB; Rayana CB; Mahjoub T; Almawi WY
    Clin Vaccine Immunol; 2011 Jun; 18(6):990-3. PubMed ID: 21490167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus.
    Serjeantson SW; Kohonen-Corish MR; Rowley MJ; Mackay IR; Knowles W; Zimmet P
    Diabetologia; 1992 Oct; 35(10):996-1001. PubMed ID: 1360432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.
    Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y
    Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agents failure.
    Fukui M; Nakano K; Maruya E; Saji H; Ohta K; Ohta M; Obayashi H; Mori H; Kajiyama S; Wada S; Shigeta H; Kitagawa Y; Nakamura N; Kondo M
    Clin Immunol Immunopathol; 1997 Nov; 85(2):182-6. PubMed ID: 9344701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
    Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes.
    Cerna M; Novota P; Kolostova K; Cejkova P; Zdarsky E; Novakova D; Kucera P; Novak J; Andel M
    Eur J Immunogenet; 2003 Dec; 30(6):401-7. PubMed ID: 14675393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes.
    Battelino T; Ursic-Bratina N; Dolzan V; Stopar-Obreza M; Pozzilli P; Krzisnik C; Vidan-Jeras B
    Eur J Immunogenet; 2003 Jun; 30(3):223-7. PubMed ID: 12787001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
    Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
    Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-associated cellular response to GAD in type 2 diabetes with antibodies to GAD.
    Fukui M; Nakamura N; Nakano K; Kajiyama S; Matsuo S; Obayashi H; Ohta M; Shigeta M; Shigeta H; Kitagawa Y; Kondo M
    Endocr J; 2000 Dec; 47(6):753-61. PubMed ID: 11228050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GAD65 autoantibody in Taiwanese patients with insulin-dependent diabetes mellitus: effect of HLA on anti-GAD65 positivity and clinical characteristics.
    Chuang LM; Lin CY; Wu HP; Tsai WY; Tai TY; Lin BJ
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):455-61. PubMed ID: 9404444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rare HLA-DQA1*03-DQB1*02 haplotype confers susceptibility to type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects.
    van Autreve JE; Weets I; Gulbis B; Vertongen F; Gorus FK; van der Auwera BJ;
    Hum Immunol; 2004 Jul; 65(7):729-36. PubMed ID: 15301863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.